智翔金泰2023年报及24年一季报点评:GR1501获批在即,管线后备力量充足
Chongqing Genrix Biopharmaceutical (688443) 国泰君安·2024-04-30 05:32
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-----------------------------------------------|--------------------------------------|------------------------------------------------------------------|------------------|-----------------------------------------------------------|----------------------|------------|-----------------------------------------------------|---------------|-------------------| | [Table_MainInfo] [Table_Title] \n智翔金泰 | -U(688443) | | | | [Table_industryInfo] | | [Ta ...